Clinical Trial Update: Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"

View source ↗

Summary

Clinical trial update on voglibose tablets evaluating long-term use in patients with impaired glucose tolerance; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance

Drugs mentioned

• voglibose tablets 0.2 (voglibose)

Snippet

Sponsor: Takeda | Conditions: Impaired Glucose Tolerance | Status: COMPLETED | Results posted: 2018-11-02